Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
131 Leser
Artikel bewerten:
(0)

Active-Investors: Ex-Dividend Alert: Nu Skin Enterprises Boosted its Dividend By 1.5%; Will Trade Ex-Dividend on February 23, 2018

LONDON, UK / ACCESSWIRE / February 22, 2018 / Active-Investors has a free review on Nu Skin Enterprises, Inc. (NYSE: NUS) following the Company's announcement that it will begin trading ex-dividend on February 23, 2018. To capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date that is by latest at the end of the trading session on February 22, 2018. Active-Investors has initiated due-diligence on this dividend stock. Register with us for more free research including the one on NUS:

www.active-investors.com/registration-sg/'symbol=NUS

If your portfolio includes dividend stocks, you have come to the right place for timely information. All you need to do is sign up for your free membership at:

www.active-investors.com/registration-sg

Dividend Declared

On February 15, 2018, Nu Skin announced that its board of directors has increased the quarterly cash dividend to $0.365 from the previous $0.36 per share. The quarterly dividend will be paid on March 14, 2018, to shareholders of record on February 26, 2018.

"Raising our dividend for the 17th consecutive year indicates our ongoing commitment to increasing shareholder value by utilizing our strong financial position," said Ritch Wood, CEO.

Nu Skin's indicated dividend represents a yield of 2.11%, which is substantially higher than the average dividend yield of 1.91% for the Services sector. The Company has raised dividend for seventeen years in a row.

Dividend Insight

Nu Skin has a dividend payout ratio of 41.1%, which denotes that the Company spends approximately $0.41 for dividend distribution out of every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts' estimates, Nu Skin is forecasted to report earnings of $4.01 for the next year, which is more than double compared to the Company's annualized dividend of $1.46 per share.

As of December 31, 2017, Nu Skin's cash and cash equivalents totaled $426.40 million compared to $357.25 million as on December 31, 2016. The Company's total assets on December 31, 2017, were $1.59 billion, while total liabilities came in at $886.28 million. The Company's strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain the dividend distribution for a long period.

Recent Development for Nu Skin

On January 25, 2018, Nu Skin announced the consumer launch of ageLOC LumiSpa, the first-of-its-kind, dual-action skin care device that treats and cleanses the skin. The Company stated that following successful market previews, ageLOC LumiSpa is now available in the Americas and Europe, Middle-East, and Africa (EMEA) regions with launches to follow in North Asia, Greater China, and Southeast Asia over the next three months.

About Nu Skin Enterprises, Inc.

Founded more than 30 years ago, Nu Skin develops and distributes innovative consumer products, offering a comprehensive line of premium-quality beauty and wellness solutions. The Company builds upon its scientific expertise in both skin care and nutrition to continually develop innovative product brands that include the Nu Skin® personal care brand, the Pharmanex® nutrition brand, and most recently, the ageLOC® anti-aging brand. The Company sells its products through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific.

Stock Performance Snapshot

February 21, 2018 - At Wednesday's closing bell, Nu Skin Enterprises' stock slightly rose 0.42%, ending the trading session at $71.66.

Volume traded for the day: 774.35 thousand shares, which was above the 3-month average volume of 369.91 thousand shares.

Stock performance in the last month - up 1.16%; previous three-month period - up 12.58%; past twelve-month period - up 49.04%; and year-to-date - up 5.03%

After yesterday's close, Nu Skin Enterprises' market cap was at $3.97 billion.

Price to Earnings (P/E) ratio was at 30.29.

The stock has a dividend yield of 2.01%.

The stock is part of the Consumer Goods sector, categorized under the Personal Products industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.